MSB 2.26% 90.5¢ mesoblast limited

Mesoblast hit with 4th shareholder class action, page-218

  1. 259 Posts.
    lightbulb Created with Sketch. 666
    "MSCs haven't been proven to have a significant effect yet, haven't been shown to have significant side effects either."

    To imply that a drug (or medical intervention) that has not been shown to have significant side effects by nature has no significant effects is speaking "fluent arse". Examples are plenty where newer generation drugs across many disease areas have shown similar efficacy with superior safety profiles. Pharma doesn't spend billions trying to improve safety profiles at the expense of efficacy. It can, has and will continue to be done. Please back up your opinion that MSC (or any other drug/medical intervention) needs to demonstrate significant side effects to demonstrate effectiveness as this is not the first time you are pushing this "fluent arse" position. Good luck trying to justify your position with evidence rolleyes.png

    I suppose you would not give a patient a blood transfusion, a third generation drug with superior efficacy and safety profile etc? Your poor pretend patients rolleyes.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
90.5¢
Change
0.020(2.26%)
Mkt cap ! $1.033B
Open High Low Value Volume
88.5¢ 95.0¢ 88.0¢ $5.610M 6.115M

Buyers (Bids)

No. Vol. Price($)
12 317774 90.0¢
 

Sellers (Offers)

Price($) Vol. No.
91.5¢ 23500 2
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.